« FDA Approvals - Anika Therapeutics Receives FDA Approvable Letter For Its Cosmetic Tissue | Main | FDA Announces Public Workshop on Marketed Unapproved Drugs FDA will »

Orbis Clinical Meets Growing Demands of Intensified FDA Regulations (Business


Orbis Clinical Meets Growing Demands of Intensified FDA Regulations (Business Wire via Yahoo! Finance)
WOBURN, Mass.----Orbis Clinical has announced that it has completed its move to Woburn, Massachusetts. The firm, which is dedicated to providing today's hottest biotechnology and pharmaceutical companies with the human resources, strategy, education and expertise required to effectively launch a drug in today's safety-conscious world, employs medical professionals around the globe.
 

©2006 FDA-News.com. All rights reserved.